Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcabene Efficacy in Low HDL-C
NCT02585869Phase 2Completed
- Sponsor
- NeuroBo Pharmaceuticals
- Start
- Dec 1999
- Primary completion
- Jun 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gemcabene in hypercholesterolemia, hypertriglyceridemia, sponsored by NeuroBo Pharmaceuticals. Started Dec 1999; status: completed.
02
Drugs
gemcabene
03
Conditions
hypercholesterolemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT02585869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02585869.